Technical Analysis for HRTX - Heron Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 17.81 -1.38% -0.25
HRTX closed down 1.38 percent on Monday, May 20, 2019, on 73 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical HRTX trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -1.38%
1,2,3 Retracement Bearish Bearish Swing Setup -2.52%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.52%
MACD Bullish Signal Line Cross Bullish -2.52%
Wide Bands Range Expansion -2.52%
Up 3 Days in a Row Strength -2.52%
Inside Day Range Contraction -1.77%
Wide Bands Range Expansion -1.77%
Wide Bands Range Expansion -1.71%

Older signals for HRTX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Medicine Health Pharmaceutical Clinical Medicine Oncology Chemotherapy Cancer Treatments Antineoplastic Drugs Occupational Safety And Health Drug Delivery Injectable Pharmaceuticals
Is HRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 42.9
52 Week Low 16.2
Average Volume 1,344,295
200-Day Moving Average 27.9665
50-Day Moving Average 22.4566
20-Day Moving Average 19.413
10-Day Moving Average 17.806
Average True Range 1.0323
ADX 40.22
+DI 16.6666
-DI 34.214
Chandelier Exit (Long, 3 ATRs ) 21.4631
Chandelier Exit (Short, 3 ATRs ) 19.2969
Upper Bollinger Band 24.6937
Lower Bollinger Band 14.1323
Percent B (%b) 0.35
BandWidth 54.40375
MACD Line -1.5305
MACD Signal Line -1.6587
MACD Histogram 0.1282
Fundamentals Value
Market Cap 964.19 Million
Num Shares 54.1 Million
EPS -4.15
Price-to-Earnings (P/E) Ratio -4.29
Price-to-Sales 59.70
Price-to-Book 11.60
PEG Ratio -0.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.71
Resistance 3 (R3) 18.72 18.43 18.56
Resistance 2 (R2) 18.43 18.20 18.43 18.51
Resistance 1 (R1) 18.12 18.06 17.98 18.11 18.46
Pivot Point 17.83 17.83 17.76 17.83 17.83
Support 1 (S1) 17.52 17.60 17.38 17.51 17.16
Support 2 (S2) 17.23 17.46 17.23 17.11
Support 3 (S3) 16.92 17.23 17.06
Support 4 (S4) 16.91